Jaime Bartushak
2021
In 2021, Jaime Bartushak earned a total compensation of $602.9K as Chief Financial Officer at Citius Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
Bonus | $20,000 |
---|---|
Non-Equity Incentive Plan | $144,625 |
Option Awards | $101,983 |
Salary | $301,667 |
Other | $34,636 |
Total | $602,911 |
Bartushak received $301.7K in salary, accounting for 50% of the total pay in 2021.
Bartushak also received $20K in bonus, $144.6K in non-equity incentive plan, $102K in option awards and $34.6K in other compensation.
Rankings
In 2021, Jaime Bartushak's compensation ranked 10,304th out of 12,415 executives tracked by ExecPay. In other words, Bartushak earned more than 17.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,304 | 17th |
Manufacturing | 4,566 | 17th |
Chemicals And Allied Products | 2,043 | 14th |
Drugs | 1,812 | 14th |
Pharmaceutical Preparations | 1,344 | 13th |
Bartushak's colleagues
We found three more compensation records of executives who worked with Jaime Bartushak at Citius Pharmaceuticals in 2021.
News
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018